Loading...

Reduced number of hypoglycemic events2,3

Lowered HbA1c1

Reduced resource utilization4,5

41%

reduction in # of hypoglycemic events for T1DM2

(<55 mg/dL; −0.38/24-h day; P<0.0001)

44%

reduction in # of hypoglycemic events for T2DM3

(<55 mg/dL; −0.12/24-h day; P=0.0017)

Meta-analysis

In a 29-study meta-analysis across 1723 participants, the FreeStyle Libre 14 day system significantly reduced HbA1c.1,*

A 0.55% average reduction in HbA1c was observed in the first 2 months and was sustained over a 12-month period.

The higher the initial HbA1c, the greater the reduction. No significant differences were seen based on study length, type of diabetes, or age.

66%

reduction in diabetes-related hospital admissions4

(P<0.05)

0.9%

reduction in HbA1c among T2DM patients on insulin6

(P<0.0001)

77%

of FreeStyle Libre 14 day system users reported reductions in hypoglycemic events4

CGM helps Dr Wright prevent and detect hypoglycemia.

Phone and CGM FreeStyle Libre sensor and reader product image

Contact us

* A meta-analysis of real-world observational studies on the impact of flash continuous glucose monitoring on glycemic control as measured by HbA1c.
Ɨ Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.


References: 1. Evans M, et al. [published online October 31, 2019]. Diabetes Ther. 2020;11:83-95. doi:10.1007/s13300-019-00720-0 2. Bolinder J, et al. Lancet. 2016;388(10057):2254-2263. 3. Haak T, et al. Diabetes Ther. 2017;8(1):55-73. 4. Fokkert M, et al. BMJ Open Diabetes Res Care. 2019;7(1):e000809. doi:10.1136/bmjdrc-2019-000809 5. Charleer S, et al. Diabetes Care. 2020;43(2):389-397. 6. Kroeger J, et al. Diabetes. 2019;68(suppl 1):99-LB. doi:10.2337/db19-99-LB

ADC-17131 v2.0 07/20

Indications and Important Safety Information

FreeStyle Libre 14 day system: The FreeStyle Libre 14 day Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device indicated for the management of diabetes in persons age 18 and older. It is designed to replace blood glucose testing for diabetes treatment decisions. The System detects trends and tracks patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Interpretation of the System readings should be based on the glucose trends and several sequential readings over time. The System is intended for single patient use and requires a prescription.

CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The FreeStyle Libre 14 day system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The FreeStyle Libre 14 day system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. Review all product information before use or contact Abbott Toll Free (855-632-8658) or visit www.freestylelibre.us for detailed indications for use and safety information. For full indications for use and safety information, see more here.

FreeStyle Libre 2 system: The FreeStyle Libre 2 Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device with real time alarms capability indicated for the management of diabetes in persons age 4 and older.*

WARNINGS/LIMITATIONS*: The System must not be used with automated insulin dosing (AID) systems, including closed loop and insulin suspend systems. Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment. Do not take high doses of vitamin C (more than 500 mg per day), as this may falsely raise your Sensor readings. Failure to use the System according to the instructions for use may result in missing a severe low blood glucose or high blood glucose event and/or making a treatment decision that may result in injury. If glucose alarms and readings from the System do not match symptoms or expectations, use a fingerstick blood glucose value to make diabetes treatment decisions. Seek medical attention when appropriate and contact Abbott Toll Free (855-632-8658) or visit * www.freestylelibre.us for detailed indications for use and safety information.

* Please refer to www.freestylelibre.us for the indications and important safety information.

The shape of the circle sensor unit, FreeStyle, Libre, and related brand marks are owned by Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company. Product images are for illustrative purposes only.

ADC-25347 v2.0 09/20